A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment.
A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment.
复制标题
DOI：
10.1002/pbc.23320
复制
发表时间：
2012-07-15
影响因子：
3.2
通讯作者：
Reilly, Anne
中科院分区：
文献类型：
--
作者：
Kazak, Anne E.;Hocking, Matthew C.;Ittenbach, Richard F.;Meadows, Anna T.;Hobbie, Wendy;DeRosa, Branlyn Werba;Leahey, Ann;Kersun, Leslie;Reilly, Anne
我们以前开发了一种可靠有效的方法来分类儿科癌症治疗的强度。治疗强度评定量表（ITR-2.0）将治疗分为四个操作定义的强度水平，并由儿科肿瘤专家根据病历中的诊断、分期和治疗数据完成。ITR-2.0的经验和治疗方案的最新变化表明需要进行小幅修订和重新验证。五名标准评分员审查了先前的项目，独立提出了疾病/治疗分类的增加和/或变更。在对拟议变更进行小组讨论之后，对修订后的43项ITR进行了评价。儿科肿瘤学家（n = 47）完成了两部分在线问卷。分类的有效性由肿瘤学家将每种疾病/治疗分为四个强度水平之一确定。评估者间的可靠性是通过让每位肿瘤学家使用我们称为ITR-3的新版本对12例样本患者的治疗进行分类来计算的。儿科肿瘤学家和标准评分者对43个项目的中位评分之间的一致性很高（r = 0.88）。评分者的中位数要么与标准评分相同（81%），要么相差一个水平。当使用ITR-3对12例样本患者进行分类时，评估者间的可靠性非常高，一致性中位数为0.90，组内相关系数（rICC = 0.86）。通过这些微小的修改和更新，ITR-3仍然是对儿科肿瘤治疗方案进行分类的可靠和有效的方法。
We previously developed a reliable and valid method for classifying the intensity of pediatric cancer treatment. The Intensity of Treatment Rating Scale (ITR-2.0) classifies treatments into four operationally defined levels of intensity and is completed by pediatric oncology specialists based on diagnosis, stage, and treatment data from the medical record. Experience with the ITR-2.0 and recent changes in treatment protocols indicated the need for a minor revision and revalidation. Five criterion raters reviewed the prior items, independently proposing additions and/or changes in the classification of diseases/treatments. Subsequent to a group discussion of the proposed changes, a revised 43 item ITR was evaluated. Pediatric oncologists (n = 47) completed a two-part online questionnaire. Validity of the classifications was determined by the oncologists classifying each disease/treatment into one of the four levels of intensity. Inter-rater reliability was calculated by having each oncologist classify the treatments of 12 sample patients using the new version which we call the ITR-3. Agreement between median ratings of the 43 items for the pediatric oncologists and the criterion raters was high (r = 0.88). The median of the raters was either identical (81%) with the criterion ratings or discrepant by one level. Inter-rater reliability was very high when using the ITR-3 to classify 12 sample patients, with a median agreement of 0.90 and an intraclass correlation coefficient (rICC = 0.86). With these minor modifications and updates, the ITR-3 remains a reliable and valid method for classifying pediatric oncology treatment protocols.
登录
查看更多内容
DOI：
10.3122/jabfm.2010.03.090215
发表时间：
2010-05
期刊：
Journal of the American Board of Family Medicine : JABFM
影响因子：
--
作者：
Schwartz LA;Mao JJ;Derosa BW;Ginsberg JP;Hobbie WL;Carlson CA;Mougianis ID;Ogle SK;Kazak AE
通讯作者：
Kazak AE
影响因子：
3.2
作者：
McCarthy, Maria C.;Clarke, Naomi E.;Anderson, Vicki A.
通讯作者：
Anderson, Vicki A.
影响因子：
29.4
作者：
Goldsby, Robert;Chen, Yan;Diller, Lisa
通讯作者：
Diller, Lisa
影响因子：
3.6
作者：
Barakat LP;Marmer PL;Schwartz LA
通讯作者：
Schwartz LA
影响因子：
2.4
作者：
Stehl, Meredith J. Lutz;Kazak, Anne E.;Douglas, Steven D.
通讯作者：
Douglas, Steven D.